跳轉至內容
Merck
全部照片(2)

文件

GF96794106

foil, not light tested, 100x100mm, thickness 0.009mm, 99.85%

同義詞:

登入查看組織和合約定價


About This Item

線性公式:
Fe
CAS號碼:
分子量::
55.85
MDL號碼:
分類程式碼代碼:
12141721
PubChem物質ID:
NACRES:
NA.23

化驗

≥99.85%

形狀

foil

製造商/商標名

Goodfellow 967-941-06

電阻係數

9.71 μΩ-cm

bp

2750 °C (lit.)

mp

1535 °C (lit.)

密度

7.86 g/mL at 25 °C (lit.)

SMILES 字串

[Fe]

InChI

1S/Fe

InChI 密鑰

XEEYBQQBJWHFJM-UHFFFAOYSA-N

一般說明

For updated SDS information please visit www.goodfellow.com.

法律資訊

Product of Goodfellow

分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Jun-Won Jang et al.
Water science and technology : a journal of the International Association on Water Pollution Research, 59(12), 2503-2507 (2009-06-23)
Zero valent iron has been successfully used for the degradation of a wide range of contaminants. However, this reaction of using ZVI particle produces a large quantity of iron sludge. To solve the problem, we report the synthesis of self-organized
Qiu et al.
Physical review letters, 85(7), 1492-1495 (2000-09-06)
FeF (2) films are grown by the reaction of XeF (2) and SeF (6) with iron foil. The growth initially follows the Mott-Cabrera parabolic rate law, indicating that the process is diffusion limited. At a certain film thickness, however, the
Arnold L Demain et al.
Applied microbiology and biotechnology, 73(1), 55-59 (2006-04-20)
When tetanus toxin is made by fermentation with Clostridium tetani, the traditional source of iron is an insoluble preparation called reduced iron powder. This material removes oxygen from the system by forming FeO(2) (rust). When inoculated in a newly developed
Antonino Missineo et al.
Infection and immunity, 82(6), 2448-2459 (2014-04-02)
Staphylococcus lugdunensis is a coagulase-negative staphylococcus that is a commensal of humans and an opportunistic pathogen. It can cause a spectrum of infections, including those that are associated with the ability to form biofilm, such as occurs with endocarditis or
Maria Wilhelm et al.
Clinical nephrology, 81(4), 251-258 (2014-03-25)
Hyperphosphatemia in advanced chronic kidney disease (CKD) necessitates the use of phosphate binders. This in vitro study assessed phosphate binding and Fe release properties of the novel iron-based phosphate binder PA21. Phosphate adsorption and Fe release were assessed under conditions

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務